Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chunkai Zhu
Upregulated lncRNA SNHG1 Contributes to Progression of Non-Small Cell Lung Cancer Through Inhibition of miR-101-3p and Activation of WNT/Β-Catenin Signaling Pathway
Oncotarget
Oncology
Related publications
Upregulated lncRNA ADAMTS9-AS2 Suppresses Progression of Lung Cancer Through Inhibition of miR-223-3p and Promotion of TGFBR3
IUBMB Life
Biochemistry
Genetics
Clinical Biochemistry
Cell Biology
Molecular Biology
Circ-Sox4 Promotes Non-Small Cell Lung Cancer Progression by Activating the WNT/Β-Catenin Pathway
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
miR-650 Promotes Non-Small Cell Lung Cancer Cell Proliferation and Invasion by Targeting ING4 Through WNT-1/Β-Catenin Pathway
Oncology Letters
Cancer Research
Oncology
Overexpression of RNF146 in Non-Small Cell Lung Cancer Enhances Proliferation and Invasion of Tumors Through the WNT/Β-Catenin Signaling Pathway
PLoS ONE
Multidisciplinary
Repression of lncRNA-SVUGP2 Mediated by EZH2 Contributes to the Development of Non-Small Cell Lung Cancer via Brisking WNT/Β-Catenin Signal
Artificial Cells, Nanomedicine and Biotechnology
Medicine
Biotechnology
Biomedical Engineering
Pharmaceutical Science
Curcumin Suppresses Cell Proliferation Through Inhibition of the WNT/Β-Catenin Signaling Pathway in Medulloblastoma
Oncology Reports
Medicine
Cancer Research
Oncology
LncRNA TATDN1 Contributes to the Cisplatin Resistance of Non-Small Cell Lung Cancer Through TATDN1/miR-451/TRIM66 Axis
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
LncRNA SNHG12 Contributes to Multidrug Resistance Through Activating the MAPK/Slug Pathway by Sponging miR-181a in Non-Small Cell Lung Cancer
Oncotarget
Oncology
MicroRNA-545 Targets ZEB2 to Inhibit the Development of Non‑small Cell Lung Cancer by Inactivating WNT/Β-Catenin Pathway
Oncology Letters
Cancer Research
Oncology
